DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF

1 API Suppliers
1 USDMF

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 14846-62-9, Chembl43326, G484l3u0o2, Nsc321803, Nsc-321803, Estra-1,3,5(10)-trien-17-one, 3-methoxy-4-nitro-

Molecular Formula

C₁₉H₂₃NO₄

Molecular Weight

329.4 g/mol

InChI Key

QDFCXLJPTBSDPF-BFDPJXHCSA-N

FDA UNII

G484L3U0O2

4-Nitroestrone 3-Methyl Ether is a synthetic derivative of estradiol. 4-nitroestrone 3-methyl ether inhibits estrogen sulfotransferase (EST), a progesterone-induced secretory endometrial enzyme which affects estrogen receptor levels. This agent has been shown to be an effective growth inhibitor of some chemically induced animal mammary tumors. (NCI04)

1 2D Structure

4-Nitroestrone 3-Methyl Ether

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(8R,9S,13S,14S)-3-methoxy-13-methyl-4-nitro-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one

2.1.2 InChI

InChI=1S/C19H23NO4/c1-19-10-9-12-11-5-7-16(24-2)18(20(22)23)14(11)4-3-13(12)15(19)6-8-17(19)21/h5,7,12-13,15H,3-4,6,8-10H2,1-2H3/t12-,13-,15+,19+/m1/s1

2.1.3 InChI Key

QDFCXLJPTBSDPF-BFDPJXHCSA-N

2.1.4 Canonical SMILES

CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4[N+](=O)[O-])OC

2.1.5 Isomeric SMILES

C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4[N+](=O)[O-])OC

2.2 Other Identifiers

2.2.1 UNII

G484L3U0O2

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 14846-62-9

2. Chembl43326

3. G484l3u0o2

4. Nsc321803

5. Nsc-321803

6. Estra-1,3,5(10)-trien-17-one, 3-methoxy-4-nitro-

7. 3-methoxy-4-nitro-estra-1,3,5(10)-trien-17-one

8. Nsc 321803

9. (8r,9s,13s,14s)-3-methoxy-13-methyl-4-nitro-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-17-one

10. Unii-g484l3u0o2

11. Schembl9362693

12. Dtxsid90163991

13. Zinc3780812

14. Bdbm50028411

15. Nci-321803

16. Nci60_002792

17. 3-methoxy-4-nitro-1,3,5(10)-estratrien-17-one

18. Estra-1,5[10]-trien-17-one, 3-methoxy-4-nitro-

19. Q27896339

20. 3-methoxy-13-methyl-4-nitro-6,7,8,9,11,12,13,14,15,16-decahydro-cyclopenta[a]phenanthren-17-one

2.4 Create Date

2005-03-26

3 Chemical and Physical Properties

Molecular Formula	C₁₉H₂₃NO₄
Molecular Weight	329.4 g/mol
XLogP3	3.3
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	1
Exact Mass	329.16270821 g/mol
Monoisotopic Mass	329.16270821 g/mol
Topological Polar Surface Area	72.1 Å²
Heavy Atom Count	24
Formal Charge	0
Complexity	544
Isotope Atom Count	0
Defined Atom Stereocenter Count	4
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1